PSTX Poseida Therapeutics
- 3.060
- +0.090+3.03%
Poseida Therapeutics News
Poseida Therapeutics | 10-Q: Quarterly report
Poseida Therapeutics | 8-K: Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Poseida Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Novartis Pharma AG(0%),Novartis AG(0%)
Poseida Therapeutics | EFFECT: Others
Poseida Therapeutics | 8-K: Current report
Poseida Therapeutics | ARS: Annual Report to Security Holders
Poseida Therapeutics | DEFA14A: Others
Poseida Therapeutics | DEF 14A: Definitive information statements
Poseida Therapeutics | 8-K: Current report
Poseida Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Poseida Therapeutics | 8-K: Current report
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rizvi Syed Ali-aamir
Poseida Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Rizvi Syed Ali-aamir
Poseida Therapeutics | 10-K: Annual report
Poseida Therapeutics | 8-K: Poseida Therapeutics Provides Updates and Financial Results for the Fourth Quarter and Full Year 2023
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Mylet Johanna
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LEONHARDT HARRY J
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gergen Mark J
Poseida Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Warner Brent
Poseida Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(14.999%),Abigail P. Johnson(14.999%)
Analysis
Price Target
No Data
